Phase
Condition
Atherosclerosis
Hypercholesterolemia
Vascular Diseases
Treatment
The patient will receive two intravenous injections of the same gadoterate meglumine contrast agent.
Two gadolinium contrast injections were administered to the patient
Clinical Study ID
Ages 18-95 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 years;
Moderate to severe intracranial or extracranial arterial stenosis (stenosis degree: 50% to 99%, confirmed by CTA, MRA, or DSA);
Written informed consent signed by the patient or their legal representative.
Exclusion
Exclusion Criteria:
Non-atherosclerotic intracranial arterial stenosis, such as dissection or moyamoyadisease;
Contraindications to MRI, such as claustrophobia or presence of a cardiac pacemaker;
Allergy to gadolinium-based contrast agents;
Poor MRI image quality preventing analysis;
Abnormal liver or kidney function;
History of any prior endovascular treatment;
Presence of implants posing potential safety risks in 5.0T MRI, such asnon-removable metallic dental prostheses, stents, or other metallic implants.
Study Design
Connect with a study center
Shanghai Sixth People's Hospital, Shanghai,200023
Shanghai,
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.